search

All clinical trials

Results 463651-463660 of 470744

Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder...

Major Depressive DisorderMetabolic Syndrome1 more

Aim 1 is to study prevalence and 1 year incidence of metabolic syndrome in major depressive disorder and factors correlation. Aim 2 is to study prevalence and 1 year incidence of thyroid dysfunction in major depressive disorder and factors correlation.

Unknown status3 enrollment criteria

Effectiveness Of Symbiotic Therapy In Jaundiced Patients

Postoperative InfectionsJaundice

The aim of the present study was therefore to evaluate if the perioperative administration of symbiotics reduces postoperative infectious morbidity in jaundiced patients scheduled for hepato-biliary and pancreatic surgery.

Unknown status9 enrollment criteria

A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor

AnesthesiologyPediatrics4 more

Study hypothesis: The Cardiotronic ICON non-invasive cardiac output monitor gives accurate information when placed on a patient's Right or Left side. Summary: To simultaneously compare physiologic data collected from two non-invasive cardiac output monitors placed bilaterally on pediatric patients undergoing general anesthesia. The FDA approved Cardiotronic ICON non-invasive cardiac output monitor has been validated by the manufacturer in pediatric and adult patients with leads placed on the left side. However, sometimes the surgical site and/or patient position precludes placement of the monitor leads on the left side. In such situations it would be useful to know whether placement of the monitor's leads on a patient's right side gives accurate cardiac output data. We will prospectively collect, and compare, simultaneous physiologic data for all enrolled children using two monitors, one on the patient's right side and one on the patient's left side.

Unknown status5 enrollment criteria

Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences...

Hepatocellular Carcinoma in Hepatitis C Virus Infected Patients

Prospective study to calculated the incidence of hepatocellular carcinoma in hepatitis C virus infected patients after stem cell therapy.

Unknown status15 enrollment criteria

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based...

HIVHypercholesterolemia1 more

The objective of this study is to evaluate changes in Framingham score (from low to moderate, from moderate to high) based on changes in lipid profile and other parameters from baseline to 48 weeks of HAART in naïve patients or patients in second line of treatment, considering LPV/r vs EFV based HAART. The null hyphotesis is that there is an increased Framingham score in patients treated with LPV/r as second line treatment and in patients treated with LPV/r or EFV regimen as first line treatments.

Unknown status9 enrollment criteria

Biochemical and Genetic Markers in Liver Diseases

Biochemical and Genetic Markers in Liver Diseases

Investigation of biochemical and genetic markers in liver disease that might have an influence on the course of the disease

Unknown status5 enrollment criteria

Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing...

Rectal Cancer

The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

Unknown status6 enrollment criteria

Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome...

Acute Coronary SyndromeMyocardial Infarction1 more

The new assay of troponins T (highly sensitive troponins) detects concentrations much lower than before. Few data are currently available on their kinetics during acute coronary syndrome, especially in regard to the correlation with CK MB. The aim of the present study is to describe the kinetic of highly sensitive troponins in acute coronary syndrome, to correlate it with the concentration of CK MB, and possibly to evaluate their prognostic value with respect to infarct size .

Unknown status3 enrollment criteria

Patient Satisfaction and Quality of Life Impact - PecFent®

Breakthrough Cancer Pain

National multicenter, prospective, observational study in cancer patients with chronic background pain and breakthrough pain to whom PecFent® has been prescribed under pragmatic condition by a specialist in the treatment of cancer pain conditions. • Study objectives include assessment of early treatment satisfaction.

Unknown status2 enrollment criteria

Non-invasive Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft-vs-Host Disease

Intestinal GVHDNeutropenic Enterocolitis

Intestinal acute graft-vs-host disease (GVHD) is a life-threatening complication after allogeneic hematopoietic cell transplantation. Non-invasive diagnostic procedures are still lacking and diagnosis is difficult. We hypothesized that contrast-enhanced ultrasound sonography (CEUS) could detect microcirculation changes of the bowel walls during intestinal GVHD and help to detect and monitor treatment response. We employed CEUS to prospectively evaluate intestinal GVHD in 83 consecutive transplant patients between 2008 and 2011. Fourteen /83 patients with biopsy-proven intestinal GVHD were selected as study group. Fourteen patients with biopsy-proven stomach GVHD without intestinal symptoms (N=16), normal volunteers (N=6) and patients with neutropenic enterocolitis (N=4), were chosen as control group. All patients were evaluated with both standard transabdominal ultrasonography (US) and CEUS at the onset of intestinal symptoms, during clinical follow up and at flare of symptoms. Standard US revealed non-specific bowel wall thickening, and simultaneous involvement of multiple intestinal segments in 9/14 patients. CEUS showed three distinct patterns of microcirculation changes that correlated with GVHD activity. These findings were not observed in the control group. Moreover, CEUS findings correlated with treatment response and predicted flare of intestinal symptoms. CEUS is a non-invasive, easily reproducible bed-side tool to detect and monitor intestinal GVHD.

Unknown status5 enrollment criteria
1...463654636646367...47075

Need Help? Contact our team!


We'll reach out to this number within 24 hrs